To the full analysis
Buyback calculator for National Health Investors
National Health Investors stock: key metrics
NHINational Health Investors had an operating margin of 51.5% and a return on invested capital (ROIC) of 7.5% in fiscal 2025.
Margins show how much of revenue is left over, returns on capital how hard the invested money works.
Daily figure as of 13 Nov 2026
Margins
- Gross margin
- Operating margin
- Net margin
Figures as a table
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| 2006 | 100.0% | 33.3% | 45.9% |
| 2007 | 100.0% | 87.1% | 154.8% |
| 2008 | 100.0% | 78.2% | 91.3% |
| 2009 | 100.0% | 77.3% | 100.0% |
| 2010 | 97.4% | 74.6% | 88.6% |
| 2011 | 100.0% | 74.8% | 98.1% |
| 2012 | 99.2% | 73.3% | 93.6% |
| 2013 | 99.5% | 66.1% | no data |
| 2014 | 99.7% | 59.8% | 57.2% |
| 2015 | 99.6% | 71.6% | 65.0% |
| 2016 | 99.6% | 71.5% | 61.0% |
| 2017 | 99.7% | 71.0% | 57.2% |
| 2018 | 99.6% | 71.0% | 52.4% |
| 2019 | 98.2% | 69.2% | 50.4% |
| 2020 | 97.1% | 67.6% | 55.6% |
| 2021 | 96.1% | 62.0% | 37.4% |
| 2022 | 96.5% | 47.7% | 23.9% |
| 2023 | 96.4% | 55.9% | 42.4% |
| 2024 | 96.7% | 54.9% | 41.2% |
| 2025 | 36.7% | 51.5% | 37.6% |
Returns on capital
- ROE
- ROIC
- ROA
Figures as a table
| Year | ROE | ROIC | ROA |
|---|---|---|---|
| 2006 | 16.0% | 16.5% | 11.6% |
| 2007 | 21.6% | 17.3% | 19.3% |
| 2008 | 13.4% | 15.6% | 12.6% |
| 2009 | 14.8% | 14.7% | 14.0% |
| 2010 | 15.7% | 14.2% | 13.6% |
| 2011 | 18.3% | 12.8% | 14.0% |
| 2012 | 19.8% | 12.1% | 12.9% |
| 2013 | no data | 7.5% | no data |
| 2014 | 9.8% | 4.8% | 5.1% |
| 2015 | 13.1% | 8.2% | 6.9% |
| 2016 | 12.5% | 6.4% | 6.3% |
| 2017 | 12.1% | 5.6% | 6.3% |
| 2018 | 11.1% | 5.5% | 5.6% |
| 2019 | 10.7% | 6.4% | 5.3% |
| 2020 | 12.2% | 7.6% | 5.9% |
| 2021 | 7.4% | 6.5% | 3.9% |
| 2022 | 5.2% | 5.2% | 2.6% |
| 2023 | 10.8% | 7.4% | 5.5% |
| 2024 | 10.1% | 7.5% | 5.3% |
| 2025 | 9.3% | 7.5% | 5.1% |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 31 Jan 2023)
- Valuation signal Undervalued since 11 Nov 2026, previously Fairly valued
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.